BlackRock Investment Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

BlackRock Investment Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.87M	Buy	228,042 +37,168	+19%	+$692K	﹤0.01%	1965
2016 Q3	$5.35M	Buy	190,874 +4,371	+2%	+$147K	0.01%	1426
2016 Q2	$6.53M	Buy	186,503 +45,627	+32%	+$1.43M	0.01%	1245
2016 Q1	$3.86M	Buy	140,876 +19,545	+16%	+$576K	0.01%	1547
2015 Q4	$4.15M	Buy	121,331 +460	+0.4%	+$14.4K	0.01%	1527
2015 Q3	$3.47M	Sell	120,871 -1,222	-1%	-$52.3K	﹤0.01%	1640
2015 Q2	$5.46M	Buy	122,093 +77,105	+171%	+$2.9M	0.01%	1420
2015 Q1	$1.56M	Buy	44,988 +712	+2%	+$19.4K	﹤0.01%	2209
2014 Q4	$1.21M	Buy	+44,276	New	+$1.07M	﹤0.01%	2415

Other funds holding DPLO

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock Investment Management's DPLO Position: Q4 2016 in Review

BlackRock Investment Management increased its DIPLOMAT PHARMACY, INC. (DPLO) stake by 19% in Q4 2016, buying an estimated $692K and bringing the position to 228,042 shares worth $2.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1965.

BlackRock Investment Management first reported a position in DPLO in Q4 2014 and has held it in 9 quarters since. The position peaked at $6.53M in Q2 2016. 174 funds tracked by Wall St. Rank hold DPLO as of Q4 2016.

BlackRock Investment Management held 228,042 shares of DIPLOMAT PHARMACY, INC. worth $2.87M as of Q4 2016.
BlackRock Investment Management bought 37,168 DIPLOMAT PHARMACY, INC. shares in Q4 2016, an estimated $692K.
DIPLOMAT PHARMACY, INC. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1965 holding.
BlackRock Investment Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and has held it in 9 quarters since.
BlackRock Investment Management's DIPLOMAT PHARMACY, INC. position peaked at $6.53M in Q2 2016.
174 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.